 The translational integrator, TI, was developed at Mayo Clinic Center for Regenerative Medicine to help bridge the gap between research and clinical translation. The TI assists investigators with navigating the increasingly complex regulatory landscape, providing education and guidance on FDA standards and regulatory pathways. Additionally, the TI helps identify the appropriate translational readiness criteria, project management, and subject matter expertise required for each project. This allows for a more efficient and effective transition of products from bench to bedside. This article was offered by Alexander Joel Greenberg, Nathan P. Staff, and Anthony Weintbank.